Efficacy of the Roux-en-Y Gastric Bypass Compared to Medically Managed Controls in Meeting the American Diabetes Association Composite End Point Goals for Management of Type 2 Diabetes Mellitus

Background The treatment goals recommended by the American Diabetes Association (ADA) for patients with type 2 diabetes mellitus include hemoglobin A1c (HbA1C)

Saved in:
Bibliographic Details
Published in:Obesity surgery 2012-03, Vol.22 (3), p.367-374
Main Authors: Leslie, Daniel B., Dorman, Robert B., Serrot, Federico J., Swan, Therese W., Kellogg, Todd A., Torres-Villalobos, Gonzalo, Buchwald, Henry, Slusarek, Bridget M., Sampson, Barbara K., Bantle, John P., Ikramuddin, Sayeed
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Blood Pressure
Body Mass Index
Cholesterol, LDL - blood
Clinical Research
Cohort Studies
Diabetes
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - physiopathology
Diabetes Mellitus, Type 2 - surgery
Disease management
Female
Follow-Up Studies
Gastric Bypass - statistics & numerical data
Gastrointestinal surgery
Glycated Hemoglobin A - metabolism
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Obesity, Morbid - epidemiology
Obesity, Morbid - physiopathology
Obesity, Morbid - surgery
Probability
Surgery
Treatment Outcome
United States - epidemiology
Weight Loss
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The treatment goals recommended by the American Diabetes Association (ADA) for patients with type 2 diabetes mellitus include hemoglobin A1c (HbA1C)
ISSN:0960-8923
1708-0428
DOI:10.1007/s11695-011-0494-y